Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

Clinical trial NCT00413023 · COMPLETED

Trial details

NCT number: NCT00413023
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2005-06-01
Primary completion: 2006-09-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.